Neurotoxicities associated with chemotherapeutics

Tyrosine kinase inhibitors
Common neurotoxicities include ischemic stroke, PRES, IPH, Guillain-Barre syndrome, myasthenia gravis, cerebral edema, and subdural hematoma

Monoclonal antibodies
Common toxicities include ischemic stroke, PRES, IPH, aseptic meningitis, and encephalopathy. Toxicities are very variable depending on the associated target.

Immune checkpoint inhibitors
Common toxicities include meningoencephalitis, Guillain-Barre syndrome, myasthenia gravis, cerebral edema, PRES, and seizures.